Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$354K Sell
2,941
-28
-0.9% -$3.23K 0.24% 104
2025
Q4
$313K Sell
2,969
-1,333
-31% -$125K 0.21% 111
2025
Q3
$361K Sell
4,302
-3,464
-45% -$285K 0.25% 101
2025
Q2
$615K Sell
7,766
-1,716
-18% -$136K 0.48% 68
2025
Q1
$851K Sell
9,482
-2,666
-22% -$249K 0.69% 46
2024
Q4
$1.21M Sell
12,148
-990
-8% -$102K 0.98% 29
2024
Q3
$1.49M Sell
13,138
-397
-3% -$47.2K 1.21% 20
2024
Q2
$1.68M Sell
13,535
-904
-6% -$116K 1.44% 13
2024
Q1
$1.91M Sell
14,439
-172
-1% -$21.2K 1.65% 12
2023
Q4
$1.59M Sell
14,611
-806
-5% -$83.7K 1.51% 15
2023
Q3
$1.59M Sell
15,417
-40
-0.3% -$4.31K 1.49% 13
2023
Q2
$1.78M Buy
15,457
+588
+4% +$66.8K 1.78% 8
2023
Q1
$1.62M Buy
14,869
+1,707
+13% +$184K 1.63% 10
2022
Q4
$1.46M Buy
13,162
+352
+3% +$36K 1.65% 8
2022
Q3
$1.12M Buy
12,810
+393
+3% +$35.1K 1.36% 12
2022
Q2
$1.15M Buy
12,417
+2,130
+21% +$189K 1.36% 15
2022
Q1
$870K Sell
10,287
-212
-2% -$16.7K 0.97% 28
2021
Q4
$846K Buy
+10,499
New +$836K 0.73% 39

Other funds holding MRK

DMC Group's MRK Position: Q1 2026 in Review

DMC Group reduced its Merck (MRK) stake by 0.94% in Q1 2026, selling an estimated $3.23K and leaving 2,941 shares worth $354K. The position accounts for 0.24% of the portfolio, ranked #104.

DMC Group first reported a position in MRK in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.91M in Q1 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • DMC Group held 2,941 shares of Merck worth $354K as of Q1 2026.
  • DMC Group sold 28 Merck shares in Q1 2026, an estimated $3.23K.
  • Merck made up 0.24% of DMC Group's portfolio in Q1 2026, its #104 holding.
  • DMC Group first reported a position in Merck in Q4 2021 and has held it in 18 quarters since.
  • DMC Group's Merck position peaked at $1.91M in Q1 2024.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on DMC Group's 13F filing for Q1 2026, filed 30 Apr 2026.